Prosecution Insights
Last updated: April 19, 2026

Examiner: SHUKLA, RAM R

Tech Center 1600 • Art Units: 1635 1644 1647

This examiner grants 15% of resolved cases

Performance Statistics

15.4%
Allow Rate
-44.6% vs TC avg
34
Total Applications
-1.8%
Interview Lift
1240
Avg Prosecution Days
Based on 26 resolved cases, 2023–2026

Rejection Statute Breakdown

3.7%
§101 Eligibility
19.1%
§102 Novelty
31.8%
§103 Obviousness
27.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17359181 RNA INTERFERENCE AGENTS FOR GST-PI GENE MODULATION Final Rejection Nitto Denko Corporation
17822533 Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12 Non-Final OA The Trustees of the University of Pennsylvania
17576562 ENGINEERED ITR SEQUENCES AND METHODS OF USE Non-Final OA BIOVERATIV THERAPEUTICS INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month